RUA Life Sciences【RUA】銘柄情報

RUA Life Sciences Plc (RUA) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

19.00

( - )

買値

18.00

売値

20.00

出来高

164,275

19.00 日の範囲 19.00

10.50 52 週間の範囲 26.50

時価総額

11.791M

前日終値

19.00

始値

19.00

時刻

50000

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

280,583p

発行済株式数

62,060,272

配当利回り

PER

-81.16

1 株当たり利益 (EPS)

-0

歳入

4.46M

純利益

-145.33k

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intell... RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also engages in the development and commercialization of bore polymer sealed grafts and soft tissue patches; and development of tri-leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

rualifesciences.com

本社

Irvine, United Kingdom

設立

1996

RUA Life Sciences Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker RUA. The last closing price for RUA Life Sciences was 19p. Over the last year, RUA Life Sciences shares have traded in a share price range of 10.50p to 26.50p.

RUA Life Sciences currently has 62,060,272 shares in issue. The market capitalisation of RUA Life Sciences is £11.79 million. RUA Life Sciences has a price to earnings ratio (PE ratio) of -81.16.

Cavendish - Morning Note – 30 June 2026

RUA Life Sciences delivers improved profitability as manufacturing business strengthens and spin-out strategy advances (RUA)

RUA Life Sciences (LSE:RUA) reported interim results for the six months ended 31 March 2026 showing significantly improved financial performance...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.25	7.04225352113	17.75	19	16.9	39702	18.78987834	DE
4	-1	-5	20	20	16.9	69760	19.06182129	DE
12	5.5	40.7407407407	13.5	26.5	13.5	270312	20.25219602	DE
26	5.25	38.1818181818	13.75	26.5	12.25	212595	17.651349	DE
52	6.625	53.5353535354	12.375	26.5	10.5	173410	15.44178383	DE
156	-14.5	-43.2835820896	33.5	58.5	8.65	284901	13.42776318	DE
260	-108.5	-85.0980392157	127.5	167.5	8.65	186739	18.42821308	DE